$JAZZ
Jazz Pharmaceuticals PLC

2017 Q2 Form 10-Q Financial Statement

#000123252417000134 Filed on August 08, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $394.4M $381.2M
YoY Change 3.47% 14.21%
Cost Of Revenue $28.70M $24.00M
YoY Change 19.58% 10.09%
Gross Profit $361.0M $355.1M
YoY Change 1.65% 14.45%
Gross Profit Margin 91.53% 93.17%
Selling, General & Admin $132.3M $122.6M
YoY Change 7.92% 14.46%
% of Gross Profit 36.66% 34.53%
Research & Development $40.16M $39.09M
YoY Change 2.73% 40.45%
% of Gross Profit 11.12% 11.01%
Depreciation & Amortization $29.30M $29.30M
YoY Change 0.0% 12.69%
% of Gross Profit 8.12% 8.25%
Operating Expenses $229.3M $212.4M
YoY Change 7.96% 17.72%
Operating Profit $165.0M $168.7M
YoY Change -2.19% 10.07%
Interest Expense -$18.29M -$12.12M
YoY Change 50.93% -23.34%
% of Operating Profit -11.08% -7.18%
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income $141.3M $156.6M
YoY Change -9.76% 31.87%
Income Tax $35.52M $42.11M
% Of Pretax Income 25.13% 26.89%
Net Earnings $105.6M $114.5M
YoY Change -7.77% 29.95%
Net Earnings / Revenue 26.78% 30.04%
Basic Earnings Per Share $1.76 $1.89
Diluted Earnings Per Share $1.72 $1.85
COMMON SHARES
Basic Shares Outstanding 60.10M shares 60.50M shares
Diluted Shares Outstanding 61.46M shares 62.04M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $319.2M $916.4M
YoY Change -65.17% -0.56%
Cash & Equivalents $239.2M $868.0M
Short-Term Investments $80.00M $48.40M
Other Short-Term Assets $36.45M $26.24M
YoY Change 38.88% 19.37%
Inventory $39.66M $33.29M
Prepaid Expenses $28.43M $23.14M
Receivables $238.8M $231.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $662.5M $1.231B
YoY Change -46.18% -1.13%
LONG-TERM ASSETS
Property, Plant & Equipment $136.6M $93.48M
YoY Change 46.16% 16.22%
Goodwill $926.3M $661.8M
YoY Change 39.96% -0.33%
Intangibles $3.033B $1.301B
YoY Change 133.18% 1.39%
Long-Term Investments
YoY Change
Other Assets $16.64M $37.01M
YoY Change -55.04% 64.48%
Total Long-Term Assets $4.142B $2.217B
YoY Change 86.79% 3.2%
TOTAL ASSETS
Total Short-Term Assets $662.5M $1.231B
Total Long-Term Assets $4.142B $2.217B
Total Assets $4.804B $3.448B
YoY Change 39.32% 1.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.53M $28.41M
YoY Change 0.43% 7.56%
Accrued Expenses $169.7M $157.6M
YoY Change 7.66% 7.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $36.09M $37.50M
YoY Change -3.75% 31.68%
Total Short-Term Liabilities $250.4M $226.7M
YoY Change 10.44% 0.69%
LONG-TERM LIABILITIES
Long-Term Debt $1.636B $1.142B
YoY Change 43.28% -14.67%
Other Long-Term Liabilities $144.7M $94.20M
YoY Change 53.61% 78.86%
Total Long-Term Liabilities $1.780B $1.236B
YoY Change 44.07% -11.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $250.4M $226.7M
Total Long-Term Liabilities $1.780B $1.236B
Total Liabilities $2.031B $1.463B
YoY Change 38.86% -9.48%
SHAREHOLDERS EQUITY
Retained Earnings $690.2M $324.8M
YoY Change 112.46% 78.65%
Common Stock $1.721B $1.617B
YoY Change 6.4% 6.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.201B $1.802B
YoY Change
Total Liabilities & Shareholders Equity $4.804B $3.448B
YoY Change 39.32% 1.62%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $105.6M $114.5M
YoY Change -7.77% 29.95%
Depreciation, Depletion And Amortization $29.30M $29.30M
YoY Change 0.0% 12.69%
Cash From Operating Activities $135.1M $135.0M
YoY Change 0.07% -3.91%
INVESTING ACTIVITIES
Capital Expenditures -$10.10M -$153.6M
YoY Change -93.42% 1081.54%
Acquisitions
YoY Change
Other Investing Activities -$20.00M -$52.70M
YoY Change -62.05% -5370.0%
Cash From Investing Activities -$30.10M -$206.3M
YoY Change -85.41% 1619.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -214.5M -37.70M
YoY Change 468.97% -616.44%
NET CHANGE
Cash From Operating Activities 135.1M 135.0M
Cash From Investing Activities -30.10M -206.3M
Cash From Financing Activities -214.5M -37.70M
Net Change In Cash -109.5M -109.0M
YoY Change 0.46% -180.27%
FREE CASH FLOW
Cash From Operating Activities $135.1M $135.0M
Capital Expenditures -$10.10M -$153.6M
Free Cash Flow $145.2M $288.6M
YoY Change -49.69% 88.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001232524
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60064963 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Jazz Pharmaceuticals plc
dei Trading Symbol
TradingSymbol
JAZZ
CY2016Q4 jazz Accrued Clinical Trial Liability
AccruedClinicalTrialLiability
10139000 USD
CY2017Q2 jazz Accrued Clinical Trial Liability
AccruedClinicalTrialLiability
2393000 USD
CY2016Q4 jazz Accrued Construction In Progress
AccruedConstructionInProgress
1597000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-819000 USD
CY2016Q4 jazz Accrued Contract Termination Fees Current
AccruedContractTerminationFeesCurrent
11612000 USD
CY2017Q2 jazz Accrued Contract Termination Fees Current
AccruedContractTerminationFeesCurrent
0 USD
CY2017Q2 jazz Accrued Construction In Progress
AccruedConstructionInProgress
6833000 USD
CY2016Q4 jazz Accrued Interest
AccruedInterest
5179000 USD
CY2017Q2 jazz Accrued Interest
AccruedInterest
4747000 USD
CY2016Q4 jazz Accrued Inventory Related Liabilities
AccruedInventoryRelatedLiabilities
3350000 USD
CY2017Q2 jazz Accrued Inventory Related Liabilities
AccruedInventoryRelatedLiabilities
2657000 USD
CY2016Q4 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
72344000 USD
CY2017Q2 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
74829000 USD
CY2016Q4 jazz Capital Redemption Reserve
CapitalRedemptionReserve
472000 USD
CY2017Q2 jazz Capital Redemption Reserve
CapitalRedemptionReserve
472000 USD
CY2016Q2 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
23980000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
47419000 USD
CY2017Q2 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
28672000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
53737000 USD
CY2016Q4 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2017Q2 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2016Q4 jazz Number Of Customers With Significant Accounts Receivable Balance
NumberOfCustomersWithSignificantAccountsReceivableBalance
5 Customer
CY2017Q2 jazz Number Of Customers With Significant Accounts Receivable Balance
NumberOfCustomersWithSignificantAccountsReceivableBalance
5 Customer
jazz Number Of Patents Covered In Instructions
NumberOfPatentsCoveredInInstructions
3 patent
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
8750000 USD
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
2000000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
1688000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
1548000 USD
CY2016Q2 jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
2051000 USD
jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
4145000 USD
CY2017Q2 jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
4731000 USD
jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
7106000 USD
CY2016Q4 jazz Sales Return Reserve
SalesReturnReserve
4366000 USD
CY2017Q2 jazz Sales Return Reserve
SalesReturnReserve
4032000 USD
jazz Stock Issued During Period Employee Plansand Warrants Exercises
StockIssuedDuringPeriodEmployeePlansandWarrantsExercises
14611000 USD
jazz Stock Issued During Period Employee Plansand Warrants Exercises
StockIssuedDuringPeriodEmployeePlansandWarrantsExercises
19071000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22415000 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
28529000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
234244000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
238752000 USD
CY2016Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
43363000 USD
CY2017Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
39367000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
193268000 USD
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
169701000 USD
CY2016Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3924000 USD
CY2017Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3517000 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4596000 USD
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3438000 USD
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
11643000 USD
CY2017Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
8937000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32142000 USD
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37675000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-317333000 USD
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-210249000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1665232000 USD
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1720584000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
14278000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
16320000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
50333000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52602000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25433000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49616000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27260000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
52453000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
16511000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
33761000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
17422000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
34991000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10776000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11379000 USD
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26737000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
49379000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26186000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51851000 USD
CY2016Q4 us-gaap Assets
Assets
4800227000 USD
CY2017Q2 us-gaap Assets
Assets
4804024000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
748069000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
662504000 USD
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
425963000 USD
CY2017Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
319213000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2017Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2017Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
425963000 USD
CY2017Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
319213000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
988785000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
867966000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
365963000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
239213000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-120819000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-126750000 USD
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
-1400000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
86798000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
207798000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
195198000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
299199000 USD
CY2017Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1769805000 USD
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
9737000 USD
CY2017Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
8705000 USD
CY2016Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15060000 USD
CY2017Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
20158000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10112000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-29956000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
556733000 USD
CY2017Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
551639000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1123000 USD
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8575000 USD
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2601000 USD
CY2017Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
20470000 USD
us-gaap Depreciation
Depreciation
5044000 USD
us-gaap Depreciation
Depreciation
6223000 USD
CY2017Q2 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
9005000 USD
CY2017Q2 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
1600000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.13
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.20
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.05
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.13
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
968000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3499000 USD
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.269
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.281
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.252
CY2016Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
8922000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
15855000 USD
CY2017Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9838000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
17462000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
421687000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
496798000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
610008000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
54020000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
102662000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
103661000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
104883000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
105110000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1070081000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1080344000 USD
CY2016Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1491768000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1577142000 USD
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5427000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6891000 USD
CY2017Q2 us-gaap Gain Loss On Cash Flow Hedge Ineffectiveness Net
GainLossOnCashFlowHedgeIneffectivenessNet
100000 USD
us-gaap Gain Loss On Cash Flow Hedge Ineffectiveness Net
GainLossOnCashFlowHedgeIneffectivenessNet
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-37000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-457000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
893810000 USD
CY2017Q2 us-gaap Goodwill
Goodwill
926290000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
32480000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
156614000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
264765000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
141322000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
257154000 USD
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-203000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-364000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42112000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74451000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35515000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64675000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6224000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5347000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22158000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3038000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3398000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2487000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3734000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-33072000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-476000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
25320000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15050000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5879000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
247000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2267000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
14587000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
15533000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10335000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
870000 USD
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1544000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1508000 shares
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1363000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1330000 shares
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3433688000 USD
CY2017Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3529901000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3012001000 USD
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3033103000 USD
CY2016Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-12121000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-24313000 USD
CY2017Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18294000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-37138000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13815000 USD
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21378000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
34051000 USD
CY2017Q2 us-gaap Inventory Net
InventoryNet
39658000 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1547000 USD
CY2017Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2591000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
18689000 USD
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15689000 USD
CY2016Q4 us-gaap Investments
Investments
60000000 USD
CY2017Q2 us-gaap Investments
Investments
80000000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4800227000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4804024000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
257406000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
250393000 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
2029625000 USD
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
1671894000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
36094000 USD
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
36094000 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1575801000 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
76699000 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
58652000 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
40606000 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
18047000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1993531000 USD
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1635800000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-182193000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-396155000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-218262000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33725000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
278668000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
299631000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
114502000 USD
us-gaap Net Income Loss
NetIncomeLoss
190314000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
105604000 USD
us-gaap Net Income Loss
NetIncomeLoss
192115000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
212426000 USD
us-gaap Operating Expenses
OperatingExpenses
427274000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
229343000 USD
us-gaap Operating Expenses
OperatingExpenses
469256000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
168735000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
289897000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
165043000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
301183000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
135287000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
10724000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
11333000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
13812000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
15573000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
74600000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
9245000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21155000 USD
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18951000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
29310000 USD
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
36448000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14060000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16638000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27704000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17484000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
90320000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
108432000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27704000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17484000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
89594000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
107084000 USD
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-726000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-1348000 USD
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
0 USD
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-104000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-193000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
112617000 USD
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
144690000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-967000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8000000 USD
CY2016Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
60000000 USD
CY2017Q2 us-gaap Other Short Term Investments
OtherShortTermInvestments
80000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
163244000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30859000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14278000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16320000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
150000000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
53484000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20000000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6028000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
11725000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
14611000 USD
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24501000 USD
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28433000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
19071000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
139632000 USD
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
174301000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
107490000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136626000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
350000000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
19282000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
18047000 USD
CY2016Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
8750000 USD
CY2017Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
2000000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
2000000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39091000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70343000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40157000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
85085000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
528907000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
690164000 USD
CY2016Q2 us-gaap Revenues
Revenues
381161000 USD
us-gaap Revenues
Revenues
717171000 USD
CY2017Q2 us-gaap Revenues
Revenues
394386000 USD
us-gaap Revenues
Revenues
770439000 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
379110000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
713026000 USD
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
389655000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
763333000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122618000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
251383000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
132328000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
276583000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
49616000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
52453000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
163244000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
30859000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
1706333000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1801553000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1877339000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
2201032000 USD
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4506000 USD
CY2017Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
7494000 USD
CY2017Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance On First Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
31400000 USD
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62043000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62329000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61463000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61321000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60499000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60821000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59991000 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Risk</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents, investments and derivative contracts. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and investments to the extent recorded on the balance sheet.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manage our foreign currency transaction risk and interest rate risk within specified guidelines through the use of derivatives. All of our derivative instruments are utilized for risk management purposes, and we do not use derivatives for speculative trading purposes. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, we had foreign exchange forward contracts with notional amounts totaling </font><font style="font-family:inherit;font-size:10pt;">$255.5 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the asset fair value of outstanding foreign exchange forward contracts was </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, we had interest rate swap contracts with notional amounts totaling </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;">. These outstanding interest rate swap contracts had a net liability fair value of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. The counterparties to these contracts are large multinational commercial banks, and we believe the risk of nonperformance is not material.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the U.S., and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor deteriorating economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates</font></div></div>

Files In Submission

Name View Source Status
0001232524-17-000134-index-headers.html Edgar Link pending
0001232524-17-000134-index.html Edgar Link pending
0001232524-17-000134.txt Edgar Link pending
0001232524-17-000134-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jazz-20170630.xml Edgar Link completed
jazz-20170630.xsd Edgar Link pending
jazz-20170630_cal.xml Edgar Link unprocessable
jazz-20170630_def.xml Edgar Link unprocessable
jazz-20170630_lab.xml Edgar Link unprocessable
jazz-20170630_pre.xml Edgar Link unprocessable
jazz2017q2doc.htm Edgar Link pending
jazzq22017ex101.htm Edgar Link pending
jazzq22017ex102.htm Edgar Link pending
jazzq22017ex311.htm Edgar Link pending
jazzq22017ex312.htm Edgar Link pending
jazzq22017ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending